Plus: We just got some data showing that one of the antibody drugs Eli Lilly’s developing with AbCellera might be able to help patients with COVID-19. In the group that took the medication, hospitalizations occurred in 1.7% of patients, compared to 6% of those who received a placebo. More on the results from Lilly here.
Top Pfizer executives are standing by the ambitious timeline that the drugmaking giant will have in October conclusive efficacy data for its coronavirus vaccine candidate.
Vault Health, a little-known startup for men's healthcare, is taking on coronavirus testing.
It was working with Rutgers University on a male fertility program when the pandemic hit. When Rutgers made a coronavirus test that uses saliva samples, Vault saw itself as a natural distributor.
